Experiment summary for ENCSR911ONC

doi:10.17989/ENCSR911ONC

Summary

Status
released
Assay
ChIP-seq (Histone ChIP-seq)
Target
H3K4me2
Biosample summary
Homo sapiens BLaER1 48 hours after the sample was treated with 100 nM 17β-estradiol, 10 ng/mL Interleukin-3, 10 ng/mL CSF1
Biosample Type
cell line
Replication type
isogenic
Description
H3K4me2 ChIP-Seq on BLaER1 cell line after 48 h treatment with 100 nM 17β-estradiol, 10 ng/mL Interleukin-3, 10 ng/mL CSF1.
Treatments
100 nM 17β-estradiol (CHEBI:16469) , 10 ng/mL Interleukin-3 (UniProtKB:P08700) , 10 ng/mL CSF1 (UniProtKB:P09603)
Nucleic acid type
DNA
Average fragment size
365 [1-1]970 [2-1]
Fragmentation methods
shearing (Covaris generic)
Size selection method
AMPure XP bead purification
Controls

Attribution

Community submission
Lab
Roderic Guigo, CRG
Award
ERC-2011-AdG-294653-RNA-MAPS (Roderic Guigo, CRG)
Project
community
External resources
Aliases
roderic-guigo:td_chipseq_H048H3K4me2X_experiment
Date released
May 10, 2022

Isogenic replicates

Isogenic replicate
Technical replicate
Summary
Biosample
Antibody
Library
11Homo sapiens BLaER1 cell line 48 hours after the sample was treated with 100 nM 17β-estradiol, 10 ng/mL Interleukin-3, 10 ng/mL CSF1ENCBS777PXOENCAB080COHENCLB259QYW
21Homo sapiens BLaER1 cell line 48 hours after the sample was treated with 100 nM 17β-estradiol, 10 ng/mL Interleukin-3, 10 ng/mL CSF1ENCBS766HULENCAB080COHENCLB367AVW